Zoekresultaten - 22 results
NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program
Keersmaecker; Nancy Roosens; P Van de Walle; Marc Van den Bulcke; Aline Antoniou Source: Cancers, Volume 12, Issue 11 (2020) Keywords: next-generation sequencing; hemato-oncology; oncology; external quality ...
Algorithms for molecular testing in solid tumours
Bulcke; P Pauwels Source: Belgian Journal of Medical Oncology (BJMO, Volume 13, Issue 7, Number 295 (2019) Abstract: In order to advise the Federal Government on the reimbursement of molecular tests related ...
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the commission personalised medicine
diagnosis, risk stratification and targeted treatment in haemato-oncology. In the framework of a pilot study for the implementation of next-generation sequencing in the Belgian healthcare system, the ...
Molecular test algorithms for breast tumours
Bempt; C Van den Broeck; I Vandernoot; C Sotiriou; J Van Dorpe; H Antoine-Poirel; Els Van Valckenborgh; Raicevic Gordana; Marc Van den Bulcke; P Aftimos Source: Belgian Journal of Medical Oncology, Volume ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Suzanne M; Guy, Rebecca; Hammond, Ian; Grogan, Paul; M. Arbyn; Castle, Philip E; Saville, Marion; B. Armstrong; Canfell, Karen Source: Gynecologic Oncology, Volume 152, Issue 3 (2019) Keywords: cervical ...
Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
Doren; Anouk Waeytens; Marc Van den Bulcke Source: Arch Public Health, Volume 76 (2018) Abstract: In the field of oncology research, next-generation sequencing has contributed significantly to the ...
Opportunities and challenges in oncology and molecular testing: the Belgian strategy
personalised medicine in oncology, including the reimbursement of molecular tests. Here, we propose the Belgian strategy for molecular testing within a scientific based framework and its implementation in the ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
We observe during a five-year period the socio-professional status (inability, disability, unemployment or death) of 645 workers identified in the permanent sample (EPS), having had an oncological ...
Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University Hospital.
be aware of the oncological safety as well. Health Topics: Quality of healthcare Category: A1 FOS Classification: 3.03 Health sciences ...
A dose-escalation study of combretastatin A4-phosphate in healthy dogs.
seem to be well tolerated. The severity of the neurotoxicity observed at 100 mg m(-2), although transient, does not invite to use this dose in canine oncology patients. Health Topics: Animal health ...